Deep tissue injuries therapy (PROHEAL) - Histocell
Latest Information Update: 06 Sep 2023
At a glance
- Originator Histocell
- Developer AJL Ophthalmic; Histocell; Praxis Pharmaceuticals
- Class Antihyperglycaemics; Mesenchymal stem cell therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Wounds
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Wounds in Spain (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Wounds in Spain
- 15 Jul 2016 Preclinical trials in Wounds in Spain (unspecified route)